The expression and function of miRNA-451 in non-small cell lung cancer

Cancer Letters

Volumn 311, Issue 2, 2011, Pages 203-209

  Wang, Xiao chun ^a   Tian, Li Li ^b   Jiang, Xiao Yan ^c   Wang, Yue Ying ^a   Li, De Guan ^a   She, Yi ^a   Chang, Jian Hui ^a   Meng, Ai Min ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b Beijing Centers for Diseases Control and Prevention   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Anoikis; Migration and invasion; MiRNA 451; NSCLC; Prognosis

Indexed keywords

MICRORNA; MICRORNA 451; UNCLASSIFIED DRUG;

ADULT; ANOIKIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL CYCLE ARREST; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

ANOIKIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING;

EID: 80053133038     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.026     Document Type: Article

References (17)

1. Ramalingam S., Pawlish K., Gadgeel S., Demers R., Kalemkerian G.P. Lung cancer in young patients: analysis of a surveillance, epidemiology, and end results database. J. Clin. Oncol. 1998, 16:651-657.
2. Yu S.L., Chen H.Y., Chang G.C., Chen C.Y., Chen H.W., Singh S., Cheng C.L., Yu C.J., Lee Y.C., Chen H.S., Su T.J., Chiang C.C., Li H.N., Hong Q.S., Su H.Y., Chen C.C., Chen W.J., Liu C.C., Chan W.K., Chen W.J., Li K.C., Chen J.J., Yang P.C. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
3. Zhu C.Q., Blackhall F.H., Pintilie M., Iyengar P., Liu N., Ho J., Chomiak T., Lau D., Winton T., Shepherd F.A., Tsao M.S. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Clin. Cancer Res. 2004, 10:1984-1991.
4. Zhu Z., Sanchez-Sweatman O., Huang X., Wiltrout R., Khokha R., Zhao Q., Gorelik E. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 2001, 61:1707-1716.
5. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
6. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
7. Miranda K.C., Huynh T., Tay Y., Ang Y.S., Tam W.L., Thomson A.M., Lim B., Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-1217.
8. Schmittgen T.D., Lee E.J., Jiang J. High-throughput real-time PCR. Methods Mol. Biol. 2008, 429:89-98.
9. Garzon R., Volinia S., Liu C.G., Fernandez-Cymering C., Palumbo T., Pichiorri F., Fabbri M., Coombes K., Alder H., Nakamura T., Flomenberg N., Marcucci G., Calin G.A., Kornblau S.M., Kantarjian H., Bloomfield C.D., Andreeff M., Croce C.M. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008, 111:3183-3189.
10. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., Mitsudomi T., Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.
11. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., Harris C.C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
12. Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin. Chem. 2008, 54:1696-1704.
13. Wang R., Wang Z.X., Yang J.S., Pan X., De W., Chen L.B. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011, 30:2644-2658.
14. Masaki S., Ohtsuka R., Abe Y., Muta K., Umemura T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem. Biophys. Res. Commun. 2007, 364:509-514.
15. Kovalchuk O., Filkowski J., Meservy J., Ilnytskyy Y., Tryndyak V.P., Chekhun V.F., Pogribny I.P. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther. 2008, 7:2152-2159.
16. Navarro A., Diaz T., Gallardo E., Vinolas N., Marrades R.M., Gel B., Campayo M., Quera A., Bandres E., Garcia-Foncillas J., Ramirez J., Monzo M. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J. Surg. Oncol. 2011, 103:411-415.
17. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001, 13:555-562.